FDA NDC Directory · JSON-LD · Markdown

Sodium nitroprusside

NDC 67457-839 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerMylan Institutional LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210763
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsSODIUM NITROPRUSSIDE (25 mg/mL)
Marketing started20180810
Package count1

External sources

Source: openFDA. Public-domain (CC0).